Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-084914
Filing Date
2025-06-11
Accepted
2025-06-11 17:00:04
Documents
1
Period of Report
2025-06-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7534
  Complete submission text file 0000950170-25-084914.txt   9039
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1305 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address
Valantine Hannah (Reporting) CIK: 0001855608 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 251040706